Androgen receptor and 5α‐reductase are expressed in pelvic endometriosis
- 5 November 2007
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 115 (1) , 113-117
Abstract
The aim of this study was to evaluate whether androgen receptor (AR) and the enzymes that convert testosterone into the more potent androgen dihydrotestosterone, 5α‐reductases (5α‐R1 and 5α‐R2) are expressed in pelvic endometriosis. The study involved 21 infertile women who underwent laparoscopy and were divided into two groups: control (n= 13) and endometriosis (n= 8) according to the histological and laparoscopic findings. Endometrial and endometriotic implant biopsies were performed. By reverse transcription polymerase chain reaction and immunohistochemistry, AR, 5α‐R1 and 5α‐R2 messenger RNA and protein were detected in biopsies of pelvic endometriosis, as well as in the eutopic endometrium of both groups. These findings suggest that active androgens may be formed within the endometriotic tissue and that both local and systemic androgens have the potential to act on endometriotic cells.Keywords
This publication has 6 references indexed in Scilit:
- Expression of androgen receptor and 5α‐reductases in the human normal endometrium and its disordersInternational Journal of Cancer, 2002
- Androgen, estrogen and progesterone receptor expression in the human uterus during the menstrual cycleEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2001
- Progesterone Antagonists Increase Androgen Receptor Expression in the Rhesus Macaque and Human EndometriumThe Journal of Clinical Endocrinology & Metabolism, 2001
- Do androgens have a direct effect on endometrial function? An in vitro studyFertility and Sterility, 2000
- Aromatase expression in endometriosisThe Journal of Clinical Endocrinology & Metabolism, 1996
- The inhibitory effects of danazol, danazol metabolites, gestrinone, and testosterone on the growth of human endometrial cells in vitroFertility and Sterility, 1988